BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16681999)

  • 1. Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR.
    Cho Y; Usui K; Honda S; Tahara-Hanaoka S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2006 Jun; 345(1):474-8. PubMed ID: 16681999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three complementarity-determining region-like loops in the second extracellular domain of human Fc alpha/mu receptor contribute to its binding of IgA and IgM.
    Yang X; Zhao Q; Zhu L; Zhang W
    Immunobiology; 2013 May; 218(5):798-809. PubMed ID: 23182711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor.
    Yoo EM; Trinh KR; Lim H; Wims LA; Morrison SL
    Mol Immunol; 2011 Sep; 48(15-16):1818-26. PubMed ID: 21632111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy.
    McDonald KJ; Cameron AJ; Allen JM; Jardine AG
    Biochem Biophys Res Commun; 2002 Jan; 290(1):438-42. PubMed ID: 11779189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regulation by Fcα/μ receptor (CD351) on marginal zone B cells and follicular dendritic cells.
    Shibuya A; Honda S
    Immunol Rev; 2015 Nov; 268(1):288-95. PubMed ID: 26497528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor.
    Ghumra A; Shi J; Mcintosh RS; Rasmussen IB; Braathen R; Johansen FE; Sandlie I; Mongini PK; Areschoug T; Lindahl G; Lewis MJ; Woof JM; Pleass RJ
    Eur J Immunol; 2009 Apr; 39(4):1147-56. PubMed ID: 19266484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Fcalpha/muR and pIgR distribute differently in intestinal tissues.
    Wang R; Fu Y; Zhao Q; Pan L; Zhang W
    Biochem Biophys Res Commun; 2009 Apr; 381(2):148-52. PubMed ID: 19338768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB; Ballister ER; Bjorkman PJ
    Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic domain of human Fcalpha/mu receptor is required for ligand internalization.
    Yang L; Shen L; Shao Y; Zhao Q; Zhang W
    Cell Immunol; 2009; 258(1):78-82. PubMed ID: 19393604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Fcalpha/muR isoform specifically expressed in the kidney tubules.
    Kurita N; Honda S; Usui K; Shimizu Y; Miyamoto A; Tahara-Hanaoka S; Shibuya K; Shibuya A
    Mol Immunol; 2009 Feb; 46(4):749-53. PubMed ID: 19027165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of the cytoplasmic portion for dimer formation of Fcalpha/micro receptor expressed on cell surface.
    Cho Y; Honda S; Yoshizawa Y; Takagaki K; Usui K; Shibuya A
    Mol Immunol; 2010 Jan; 47(4):878-82. PubMed ID: 19945166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgA.
    Shibuya A; Honda S
    Springer Semin Immunopathol; 2006 Dec; 28(4):377-82. PubMed ID: 17061088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the dimer formation of Fcα/μ receptor (CD351).
    Takagaki K; Satoh K; Honda S; Shibuya A
    Mol Immunol; 2013 Nov; 56(1-2):23-7. PubMed ID: 23665380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor.
    Kikuno K; Kang DW; Tahara K; Torii I; Kubagawa HM; Ho KJ; Baudino L; Nishizaki N; Shibuya A; Kubagawa H
    Eur J Immunol; 2007 Dec; 37(12):3540-50. PubMed ID: 18000956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA.
    Wines BD; Hulett MD; Jamieson GP; Trist HM; Spratt JM; Hogarth PM
    J Immunol; 1999 Feb; 162(4):2146-53. PubMed ID: 9973489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Fcα/μR (CD351) in autoantibody production.
    Yoshizawa Y; Honda S; Shibuya A
    Mol Immunol; 2014 Feb; 57(2):216-9. PubMed ID: 24172225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis.
    Shibuya A; Honda SI; Shibuya K
    Int Immunol; 2017 Dec; 29(11):519-524. PubMed ID: 29281010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fcα/μ Receptor.
    Weinstein JR; Quan Y; Hanson JF; Colonna L; Iorga M; Honda S; Shibuya K; Shibuya A; Elkon KB; Möller T
    J Immunol; 2015 Dec; 195(11):5309-17. PubMed ID: 26500348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum IgA in Fcα/μR-deficient mice on the (129 x C57BL/6) F1 genetic background.
    Kurita N; Honda S; Shibuya A
    Mol Immunol; 2015 Feb; 63(2):367-72. PubMed ID: 25282043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM and its receptors: structural and functional aspects.
    Klimovich VB
    Biochemistry (Mosc); 2011 May; 76(5):534-49. PubMed ID: 21639833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.